AU Patent

AU2014329421B2 — Stabilized efinaconazole compositions

Assigned to Dow Pharmaceutical Sciences Inc · Expires 2018-08-02 · 8y expired

What this patent protects

The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.

USPTO Abstract

The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014329421B2
Jurisdiction
AU
Classification
—
Expires
2018-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Dow Pharmaceutical Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.